Guerbet SA (GURBF)

22.25 0.00 (0.00%) USD  |  OTCM  |  Jul 06, 16:00
More

Price Chart

Key Stats

View All Stats
Price and Performance
Market Cap --
52 Week High (Daily) Upgrade
52 Week Low (Daily) Upgrade
All-Time High (Daily) Upgrade
Year to Date Total Returns (Daily) Upgrade
1 Month Total Returns (Daily) Upgrade
1 Year Total Returns (Daily) --
Valuation
PE Ratio --
PE Ratio (Forward) Upgrade
PS Ratio --
Price to Book Value --
EV to EBITDA Upgrade
Dividend
Dividend --
Dividend Yield (Forward) Upgrade
Financials
Revenue (5 Year Growth) Upgrade
Revenue (Quarterly YoY Growth) Upgrade
EPS Diluted (5 Year Growth) Upgrade
EPS Diluted (Quarterly YoY Growth) Upgrade
Debt to Equity Ratio --
Return on Equity Upgrade
Return on Assets Upgrade
Risk
Beta (5Y) Upgrade
Max Drawdown (5Y) --

Ratings

Y-Rating Upgrade
Value Score Upgrade
Fundamental Score Upgrade
Valuation (Hist. Mult.) Upgrade

Profile

Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company operates through the following segments: Diagnostic Imaging and Interventional Imaging. The Diagnostic Imaging segment includes MRI and X-Ray contrast media. The Interventional Imaging covers any invasive medical procedure whose purpose is to diagnose and treat a disease. The company was founded by André Guerbet in 1926 and is headquartered in Paris, France.
URL http://www.guerbet.com
Investor Relations URL N/A
HQ State/Province Ile-de-France
Sector  
Industry  
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jun. 29, 2023

Ratings

Y-Rating Upgrade
Value Score Upgrade
Fundamental Score Upgrade
Valuation (Hist. Mult.) Upgrade

Profile

Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company operates through the following segments: Diagnostic Imaging and Interventional Imaging. The Diagnostic Imaging segment includes MRI and X-Ray contrast media. The Interventional Imaging covers any invasive medical procedure whose purpose is to diagnose and treat a disease. The company was founded by André Guerbet in 1926 and is headquartered in Paris, France.
URL http://www.guerbet.com
Investor Relations URL N/A
HQ State/Province Ile-de-France
Sector  
Industry  
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jun. 29, 2023